Indian Pharmaceutical Alliance

FDA

FDA looks to restart inspections delayed by COVID-19

The FDA is considering a "phased approach" to restarting on-site inspections of domestic and foreign drug manufacturing facilities.

Kyle Blankenship May 14, 2020 8:55am

FDA

Indian pharmas call on FDA to permit 'virtual' inspections

Apr 30, 2020 6:09pm

Bicon Managing Director Kiran Mazumdar-Shaw

India wants to sell low-cost drugs in Trump’s America

Mar 3, 2017 8:21am